	US 11,873,345 B2
	Product and method for treating sarcopenia
Lewis S. Gruber, Chicago, IL (US)
Assigned to Siwa Corporation, Chicago, IL (US)
Filed by Siwa Corporation, Chicago, IL (US)
Filed on Jun. 13, 2019, as Appl. No. 16/440,747.
Application 16/440,747 is a continuation of application No. 14/974,561, filed on Dec. 18, 2015, granted, now 10,358,502.
Claims priority of provisional application 62/241,007, filed on Oct. 13, 2015.
Claims priority of provisional application 62/093,956, filed on Dec. 18, 2014.
Prior Publication US 2020/0055957 A1, Feb. 20, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 39/00 (2006.01); C07K 16/44 (2006.01)

CPC C07K 16/44 (2013.01) [A61K 39/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/92 (2013.01)]

20 Claims

1. A method of treating sarcopenia, comprising killing or inducing apoptosis in senescent cells in a subject by administering to a subject a composition comprising an anti-AGE antibody,

wherein the anti-AGE antibody binds a carboxymethyllysine-modified protein.